Immunic adds Elena Ridloff to board ahead of Phase 3 MS readout
The company also detailed the separation terms for former CEO Daniel Vitt as he transitions to a consulting and advisory role.
SEC filing
Latest
1 story
Sign inSign in1 story
The company also detailed the separation terms for former CEO Daniel Vitt as he transitions to a consulting and advisory role.
SEC filing